Related Experiment Video
Updated: Jun 17, 2026
08:36
The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
Published on: April 19, 2024
Treatment of viral encephalitis
1Department of Pathology, Santa Casa School of Health Sciences, EMESCAM, Vitória, ES, Brazil. renan-domingues@uol.com.br
Central Nervous System Agents in Medicinal Chemistry
|December 22, 2009
Summary
This review discusses current drug treatments for viral central nervous system infections in adults. It covers mechanisms, efficacy, and side effects for immunocompetent and immunocompromised patients.
Area of Science:
- Neurology
- Infectious Diseases
- Virology
Background:
- Viral infections can cause acute, subacute, or chronic central nervous system (CNS) diseases with diverse clinical presentations.
- Encephalitis involves direct viral invasion or post-infectious autoimmune responses, affecting neuronal damage or myelin.
- Epidemiology is influenced by lifestyle and ecological shifts, with increased incidence of certain viral CNS infections in immunocompromised individuals.
Purpose of the Study:
- To review current pharmacologic options for managing acute and chronic viral CNS infections in adults.
- To focus on drug mechanisms of action, efficacy, and potential side effects.
- To provide insights for both immunocompetent and immunocompromised patient populations.
Main Methods:
- Literature review of current antiviral and immunomodulatory therapies.
- Analysis of drug efficacy, mechanisms, and adverse effects.
- Synthesis of diagnostic and therapeutic advancements in viral encephalitis management.
Main Results:
- Advances in neuroimaging, molecular diagnostics, and treatments have improved early diagnosis and patient outcomes.
- Specific drug options for various viral CNS infections are detailed, including their therapeutic profiles.
- Despite progress, severe outcomes remain possible even with optimal management.
Conclusions:
- Early diagnosis and appropriate management are crucial for reducing mortality and neurological deficits from viral CNS infections.
- Current therapeutic strategies offer improved outcomes but require careful consideration of drug-specific profiles.
- Ongoing research and clinical advancements continue to refine the treatment landscape for viral encephalitis.
Related Concept Videos
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:25Arboviral Encephalitis
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:26Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...